| Date |
Federal Register Citation |
Description |
9/9/1976 |
41FR38312  |
Advance Notice of Proposed Rulemaking |
3/21/1980 |
45FR18400 |
Reopening of Administrative Record |
9/26/1980 |
45FR63874 |
Reopening of Administrative Record: Camphor-containing products |
7/9/1982 |
47FR30002 |
Tentative Final Monograph |
8/27/1982 |
47FR37934 |
Extension of Comment Period: Tentative Final Monograph |
8/12/1988 |
53FR30522 |
Proposed Rule: Miscellaneous combinations |
11/14/1988 |
53FR45774 |
Clarification: Includes promethazine HCl combinations (8/12/1988 Proposed Rule) |
2/28/1989 |
54FR8494 |
Final Monograph |
3/22/1989 |
54FR11866 |
Correction: Final Monograph |
9/5/1989 |
54FR36762 |
Notice: Prohibits OTC marketing of promethazine HCl |
11/28/1989 |
54FR48914 |
Reopening of Administrative Record: Promethazine HCL |
1/4/1990 |
55FR310 |
Correction: 11/28/1989 Reopening of Administrative Record |
1/24/1990 |
55FR2387 |
Extension of Comment Period: 11/28/1989 Reopening of Administrative Record |
6/30/1992 |
57FR29176 |
Technical Amendment: Replaces "sputum" with "mucus" in indications (Final Monograph) |
9/14/1992 |
57FR41857 |
Final Rule: Classifies ipecac as nonmonograph |
10/6/1992 |
57FR46067 |
Correction: 9/14/1992 Final Rule |
| 7/13/2005 |
70FR40232
[HTML] |
Proposed Rule: Bronchodilator, expectorant, and nasal decongestant combinations
nonmonograph |
| 8/16/2007 |
72FR46091 
[HTML] |
Notice: Advisory Committee Meeting |
10/1/2007 |
72R55784
[HTML] |
Amendment of Notice: Advisory Committee Meeting |
| 8/25/2008 |
73FR50033
|
Notice of Public Hearing; Request for comments |
9/1/2008 |
73FR51309
|
Notice of Public Hearing: Correction |
